Startup Capital Summit

3 Jun 2026 | Coimbra, Portugal

ServiceUpdated on 26 May 2026

TAPR

Marketing Trainee at Psychomeasure

Aveiro, Portugal

About

Class I SaMD platform that functions as a test for the mind, enabling early detection of psychosis risk through objective biomarkers assessment. With over 90% accuracy, it can predict the transition to psychosis up to two years before a clinical outbreak, while remaining completely language-independent.

Type

  • Pilot Projects, Testing & Validation
  • Business Development & Market Access
  • Partnerships & Collaborative Projects

Applies to

  • Healthcare & Life Sciences

Similar opportunities